Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Ajinomoto Bio-Pharma Services Receives FDA Approval for High Potency Fill Line
2023-04-19 20:05
Biosyngen announces FDA IND approval of its second product for EBV-positive lymphoma
2023-04-18 19:03
YS Biopharma Announces Record Vaccine Revenues and Preliminary Financial Results for FY2023 Ended March 31, 2023
2023-04-18 19:00
Daewoong Pharmaceutical and Sygnature Discovery announce drug discovery research collaboration
2023-04-18 17:16
Innovent Releases Final Analysis Results of ORIENT-16: the Phase 3 Study of Sintilimab in Combination with Chemotherapy for the First-Line Treatment of Gastric Cancer at the AACR Annual Meeting 2023
2023-04-18 08:00
Ocedurenone: A Novel Therapy for Uncontrolled Hypertension in Advanced Chronic Kidney Disease
2023-04-18 08:00
Innovent Announces Updated Data of Phase 1 Clinical Trial for IBI351 (KRAS[G12C] Inhibitor) as Monotherapy for Solid Tumors at the AACR Annual Meeting 2023
2023-04-18 08:00
Shanghai Cellular Biopharmaceutical Group presents first data from Phase I trial evaluating a novel CAR-T in advanced liver cancer at AACR Annual Meeting
2023-04-18 04:15
EXCHANGE OFFER DECLARED UNCONDITIONAL
2023-04-18 01:51
Antengene Announces Five Presentations at the 2023 American Association for Cancer Research Meeting
2023-04-17 20:22
Late-Breaking Research - Alphamab Oncology Presents Preclinical Results of KN052 at AACR 2023
2023-04-17 14:01
EBMI INKED MOA WITH SFIO TO BUILD A WORLD-CLASSS INTEGRATIVE CARE FACILITY IN PALAWAN, PHILIPPINES
2023-04-17 11:00
AffaMed Therapeutics Announces Approval to Initiate a Phase 3 Registrational Clinical Trial in Mainland China for DEXTENZA® for the Treatment of Ocular Inflammation and Pain Following Ophthalmic Surgery
2023-04-17 09:00
Innovent Releases Final Analysis Results of ORIENT-15: the Phase 3 Study of Sintilimab plus Chemotherapy for the First-Line Treatment of Esophageal Squamous Cell Carcinoma at the AACR Annual Meeting 2023
2023-04-17 08:33
Henlius Achieved Steep Revenue Growth in Q1 2023, Core Products Sales Surged
2023-04-17 07:45
Bugworks Research Inc. to Present Eight Posters at the 33rd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) 2023, in Copenhagen, Denmark
2023-04-17 07:00
Olaratumab Antibody Licensed from Lilly Demonstrates Proof of Concept as a Theranostic Radiopharmaceutical
2023-04-17 06:38
CytoMed Therapeutics Limited Announces Pricing of Initial Public Offering
2023-04-14 08:00
Menarini Silicon Biosystems new CELLSEARCH® data presented at AACR 2023 annual meeting highlights trailblazing contributions of liquid biopsies for cancer research
2023-04-13 20:36
EW GROUP SHINES AT 12TH A4M SYMPOSIUM 2023 & "ALL-ON BIOREGEN OPTIMIZATION" WORKSHOP
2023-04-13 12:20
1
38
39
40
41
42
212